PASG Passage BIO Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PASG

Price (delayed)

$5

Market cap

$16.09M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$11.33

Enterprise value

-$8.07M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 8
Highlights
The debt has plunged by 100% from the previous quarter and by 100% YoY
The EPS has grown by 37% YoY and by 4.4% from the previous quarter
The equity has plunged by 88% YoY and by 62% from the previous quarter
The quick ratio has shrunk by 60% YoY and by 30% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.passagebio.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of PASG

PASG stock price

How has the Passage BIO stock price performed over time
Intraday
1.01%
1 week
2.88%
1 month
12.61%
1 year
-33.6%
YTD
-57.63%
QTD
2.46%

Financial performance

How have Passage BIO's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$36.11M
Net income
-$36.11M
Gross margin
N/A
Net margin
N/A
The net income is up by 36% year-on-year and by 4.2% since the previous quarter
The operating income is up by 36% year-on-year and by 4.2% since the previous quarter

Price vs fundamentals

How does PASG's price correlate with its fundamentals

Growth

What is Passage BIO's growth rate over time

Valuation

What is Passage BIO stock price valuation
P/E
N/A
P/B
3.6
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 37% YoY and by 4.4% from the previous quarter
The equity has plunged by 88% YoY and by 62% from the previous quarter
The stock's price to book (P/B) is 70% more than its last 4 quarters average of 2.1

Efficiency

How efficient is Passage BIO business performance
The company's return on equity has shrunk by 110% YoY and by 45% QoQ
PASG's return on assets is down by 22% since the previous quarter and by 22% year-on-year

Dividends

What is PASG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PASG.

Financial health

How did Passage BIO financials performed over time
Passage BIO's total assets is 22% more than its total liabilities
Passage BIO's total assets has plunged by 68% YoY and by 31% from the previous quarter
The quick ratio has shrunk by 60% YoY and by 30% QoQ
The debt is 100% less than the equity
The debt to equity has plunged by 100% from the previous quarter and by 100% YoY
The debt has plunged by 100% from the previous quarter and by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.